Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised?utm_campaign=052120_PR_Coronavirus%20%28COVID-19%29%20Update%3A%20FDA%20Provides%20Promised%20Transparency%20for%20Antibody%20Tests&utm_medium=email&utm_source=Eloqua

Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests

Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the “notification list” of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency. Antibody tests on this new removal list include those voluntarily withdrawn from the notification list by the test’s commercial manufacturer and those for which there is not a pending Emergency Use Authorization (EUA) request or issued EUA. FDA expects that the tests on the removal list will not be marketed or distributed. Antibody tests offered by commercial manufacturers as ...

Read More